TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in Hemoglobin A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in resting systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flavor identification and evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific flavor detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flavor combination thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of periapical lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment rate of eligible participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Walking Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived social support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: preoperative preparation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with Observed Carcinoid Crises
Endpoint domain: Adverse events/effects
Primary endpoint: Brain functional activity and connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain (Visual Analogic Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fall prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in LAVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global rate of potentially avoidable hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Post-operative leg alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-reported pain severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Static and Dynamic Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MMP8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Large Hiatal Hernia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficacy of osimertinib plus bevacizumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of evaluable patients with objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔT at the waist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of overall neuropathy symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progression of the disease using functional measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of limitations caused by neuropathy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in the number of correct specific detail recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: digoxin renal clearance (treatment/control)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rib Cage Mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of commercial antibodies identifying breast cancer biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Peak post-operative Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Numerical Pain Rating Scale pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of pain medication- acetaminophen, ibuprofen and hydrocodone
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of lesion-specific CT-FFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arthroscopic Visual Clarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnosis according to WHO classification of CNS tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mitotic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional Ambulation Categories (FAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants engaged in comprehensive addiction treatment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Brain shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Angulation of the maxillary third molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demographic and clinical data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity and/or Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Anti-HPV geometric mean antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Brain excitability in migraine patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain connectivity in migraine patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Arterial circumference in migraine patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of adverse events / serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Controlling uterine bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 3-year Disease free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Body mass index (BMI) z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fat mass index z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: aPTT CoaguChek® Pro II POCT result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cervical Range of Motion (CRoM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Behavior Milestones Assessment and Placement Program (VB-MAPP)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pediatric Functional Independent Measure (WeeFIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short Sensory Profile™ 2 (SSP2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of subjects who achieved ASAS40 among bDMARDs and tsDMARD-naive subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who achieved ASAS40 among bDMARDs and/or tsDMARD-experienced subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of actual and anticipated recruitment rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comparison of actual and anticipated retention rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comparison of actual and anticipated attendance rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comparison of actual and anticipated completion rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants report daily music exercise use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acceptance of music therapy intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Edmonton Symptom Assessment System (ESAS++)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6 Month Progression-free survival (PFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Correct rate for alerting agitated critically ill patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical Wound Infection Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Western Ontario McMaster University Osteoarthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline Visual Analog Score (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in blood concentrations of nicotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total combined urinary concentrations of the nicotine metabolites cotinine and 3-hydroxycotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Hemoglobin (Hb) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent Change From Baseline in Platelet Count Increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants With Improvement in Thrombocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in urinary excretion of lactulose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient reported perceived attributes of e-health innovation score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in staff reported normalisation measure of the technology (NoMAD) score
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: diagnostic performance of imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of solicited local and systemic adverse events within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of unsolicited adverse events within 28 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of serious adverse events and adverse events of special interest until 6 months after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Physical Activity Behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Noise vomiting incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Mean Total Modified Lobene Stain Index (MLSI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Alive and Not Requiring Non-invasive or Invasive Ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients who received donor CD19/CD22-CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the donors safety CD19/CD22-CAR T cells plus the Orca-T graft
Endpoint domain: Adverse events/effects
Primary endpoint: Environmental Health Knowledge Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Painless Unassisted Mouth Opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Unassisted Mouth Opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Assisted Mouth Opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP treatment adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression Free Survival at 4 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shade matching evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of advanced neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Withdrawal relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WORC Physical Symptom Domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 1-year PFS rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Histological analysis of gingival biopsy tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Punctal patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Presence of Epiphora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Rate of intended target lesion and/or marker removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative resection margin rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Technical Success of the Bare Temporary Spur Stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Freedom from the occurrence of major adverse limb events (MALE)
Endpoint domain: Adverse events/effects
Primary endpoint: pain intensity at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain intensity at the posttreatment of pcTBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in urinary tract infection symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urine white blood cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in lower limb arterial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in leg vascular conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in left ventricular pulsatile load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the concentration-time curve from time zero to 12 hours postdose (AUC0-12h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of viral infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of viral infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Family Engagement (FAME) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of MRI diagnosis compared to histopathological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active range of motion of cervical and lumbar regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child fish foods intake
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: VAS score at rest and on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of thrombotic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of state-trait anxiety in children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: household food waste measured in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: household food waste measured in calories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: household FV acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: household FV intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to stable signal of heart rate estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall accuracy of heart rate estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional brain TSPO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean anterior chamber cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Performance of Masimo pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety as assessed by Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Severity and Interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytokine/chemokine/metabolite concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percentage of different non-conventional T cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Objective response rates of the central nervous system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Burden of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of major arrhythmia occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trajectories of QT prolongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in quality of life (QoL) as measured by SF-12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: changes in quality of life (QoL) as measured by Veines QoL/Sym
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Agreement between SVV-FloTrac and SVV-BioZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum Lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Angina symptoms assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prognostic value of AIMS65 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent of donor-derived cell-free DNA (ddcfDNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline of acute inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline on the Patient Oriented Eczema Measure (POEM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline on the Scoring Atopic Dermatitis Index (SCORAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline on scratching times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline on the Itchy Quality of Life (ItchyQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline on structural MRI (3D; DTI) and functional MRI (resting state; task state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ischemic cerebrovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes from Baseline in Clinical Disease Activity Index (CDAI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Erythrocyte Sedimentation Rates (ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in C-reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of low birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vaccine appointments scheduled/completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in the Brief Pain Inventory (BPI) score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in the McGill Pain Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: percentage of missed follow up data
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative change in handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery-15 (QoR-15) scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postpartum Sexual Life Quality Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VAS satisfaction scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area of severe burn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Alcohol Use Disorders Identification Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of all grade TEAEs and ≥3 grade TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious medical conditions
Endpoint domain: Adverse events/effects
Primary endpoint: Pressure Pain thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes